Managers / Q3 2024 · view latest →
LASRY MARC
CIK 0001259927
Summary
Lasry Marc reported $55M in U.S.-listed holdings across 10 positions for Q3 2024.
The portfolio is heavily concentrated: NEXT alone accounts for 53.9% of reported value.
Compared with Q2 2024, the fund opened 1 new position and exited 2.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 57.4% · $32M
- GLOBAL · 27.4% · $15M
- REIT · 8.0% · $4M
- Other · 7.0% · $4M
- PUBLIC · 0.2% · $123,997
Quarter-over-Quarter Changes full breakdown →
vs Q2 2024 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| BEYOND AIR INC | NEW | +4.95M | 4.95M | +$4M | $4M |
| PDD HOLDINGS INC | ADDED | +13.00M | 15.00M | +$13M | $15M |
| TALOTALOS ENERGY INC | SOLD OUT | −2.30M | 0 | −$28M | $0 |
| FYBRFRONTIER COMMUNICATIONS PARE | SOLD OUT | −357.5K | 0 | −$9M | $0 |
| ALXALEXANDERS INC | TRIMMED | −20.5K | 18.1K | −$4M | $4M |
| NEXTNEXTDECADE CORP | HELD | −86.2K | 6.30M | −$21M | $30M |
| OBIOORCHESTRA BIOMED HLDGS INC | HELD | +0 | 60.9K | −$183,215 | $312,867 |
| RANIRANI THERAPEUTICS HLDGS INC | HELD | +0 | 62.9K | −$103,135 | $135,836 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q3 2024
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | NEXTNEXTDECADE CORPhistory → | COM | 53.94% | $30M | 6.30M |
| 2 | PDD HOLDINGS INC | NOTE 12/0 | 27.43% | $15M | 15.00M |
| 3 | ALXALEXANDERS INChistory → | COM | 7.99% | $4M | 18.1K |
| 4 | BEYOND AIR INC | COM | 6.58% | $4M | 4.95M |
| 5 | DCTHDELCATH SYS INChistory → | COM NEW | 2.10% | $1M | 161.8K |
| 6 | OBIOORCHESTRA BIOMED HLDGS INC | COM | 0.57% | $312,867 | 60.9K |
| 7 | EYENGBPEYENOVIA INC | COM | 0.51% | $282,997 | 547.8K |
| 8 | FORGE GLOBAL HOLDINGS INC | COM | 0.41% | $223,300 | 170.5K |
| 9 | RANIRANI THERAPEUTICS HLDGS INC | COM CL A | 0.25% | $135,836 | 62.9K |
| 10 | EXELA TECHNOLOGIES INC | 6% CONV PFD SR B | 0.23% | $123,997 | 77.5K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q3 2025 | $15M | 9 | Nov 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $18M | 8 | Aug 15, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $22M | 10 | May 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $23M | 11 | Feb 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $55M | 10 | Nov 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $101M | 11 | Aug 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $117M | 11 | May 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $68M | 10 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $101M | 13 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $77M | 12 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $52M | 10 | May 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $64M | 11 | Feb 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $52M | 14 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $66M | 14 | Aug 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $201M | 16 | May 17, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $203M | 11 | Feb 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $162M | 11 | Nov 15, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $217M | 16 | Aug 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $145M | 11 | May 17, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $263M | 11 | Feb 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $155M | 6 | Nov 16, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $152M | 9 | Aug 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $122M | 11 | May 15, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $298M | 11 | Feb 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $306M | 15 | Nov 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $466M | 17 | Aug 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $557M | 16 | May 15, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $454M | 13 | Feb 14, 2019 | 13F-HR | changes · EDGAR ↗ |
Other Included Managers
This filing reports holdings on behalf of 4 additional managers.
- Avenue Capital Management II GenPar, LLC028-12377
- Avenue Capital Management II, L.P.028-11224
- Avenue Energy Opportunities Partners II, LLC028-22561
- GL Energy Opportunities Partners II, LLC028-22562
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.